BlackRock Fund Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$54.4M Buy
3,264,023
+473,788
+17% +$8.57M 0.01% 1626
2016
Q3
$57.4M Buy
2,790,235
+127,246
+5% +$3.23M 0.01% 1482
2016
Q2
$81.5M Sell
2,662,989
-67,926
-2% -$2.36M 0.02% 1139
2016
Q1
$102M Buy
2,730,915
+72,034
+3% +$2.71M 0.02% 938
2015
Q4
$115M Sell
2,658,881
-128,091
-5% -$5.41M 0.03% 853
2015
Q3
$104M Buy
2,786,972
+59,360
+2% +$2.11M 0.03% 871
2015
Q2
$92.7M Buy
2,727,612
+1,111,593
+69% +$37.8M 0.02% 1056
2015
Q1
$57.2M Buy
1,616,019
+135,261
+9% +$4.84M 0.01% 1423
2014
Q4
$50.4M Sell
1,480,758
-10,017
-0.7% -$355K 0.01% 1459
2014
Q3
$57.5M Buy
1,490,775
+23,333
+2% +$871K 0.02% 1270
2014
Q2
$57.1M Sell
1,467,442
-26,886
-2% -$1M 0.02% 1312
2014
Q1
$51.1M Buy
1,494,328
+51,866
+4% +$1.61M 0.02% 1403
2013
Q4
$30.3M Sell
1,442,462
-15,171
-1% -$384K 0.01% 1736
2013
Q3
$34.3M Buy
1,457,633
+183,450
+14% +$5.21M 0.01% 1604
2013
Q2
$34.2M Buy
+1,274,183
New +$36.9M 0.01% 1478

Other funds holding MYGN